We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Lactate Concentrations Evaluated In Suspected Infections

By LabMedica International staff writers
Posted on 16 Oct 2012
The relationship between blood lactate concentrations categorized into groups and mortality appears to be linear, but the relationship between lactate as a continuous measurement and mortality is uncertain.

The prognostic significance of incremental blood lactate concentrations among emergency department (ED) patients with suspected infection has been evaluated and categorized into low, intermediate, and high groups. More...


Scientists at the University of Mississippi Medical Center (Jackson, MS, USA) carried out a retrospective cohort analysis of adult ED patients with suspected infection from a large urban ED during January 2007 to May 2011. Over the study period, 2,596 patients met inclusion criteria and the median age was 61 years, the median hospital length of stay was eight days and the overall mortality was 14.4%.

The whole blood lactate measurements were performed in the ED using the i-STAT point-of-care (POC) measurement (Abbott Point of Care Inc.; Princeton, NJ, USA; www.abbottpointofcare.com ). The median initial lactate concentration was 2.1 mmol/L, and 459 (17.6%) subjects had an initial lactate greater than 4 mmol/L. Mortality continued to rise across the continuum of incremental elevations, from 6% for lactate greater than 1.0 mmol/L up to 39% for lactate 19-20 mmol/L. Polynomial regression analysis showed a strong curvilinear correlation between lactate and mortality.

The authors concluded that in ED patients with suspected infection, incremental elevations in whole blood lactate values up to 20 mmol/L are associated with progressive increases in mortality. Clinicians should be aware of the prognostic significance of incremental increases in lactate, even in the significantly elevated range, and should avoid considering all patients with a high lactate to be at similar risk of death. The study was published on August 20, 2012, in the journal Academic Emergency Medicine.

Related Links:
University of Mississippi Medical Center
Abbott Point of Care Inc.



New
Gold Member
Clinical Drug Testing Panel
DOA Urine MultiPlex
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated MALDI-TOF MS System
EXS 3000
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: AI-powered ctDNA analysis provides clinicians with a new lens to monitor disease evolution (Photo courtesy of Brandon Stelter, Katie Han, Kyle Smith, and Paul Northcott)

AI-Powered Liquid Biopsy Classifies Pediatric Brain Tumors with High Accuracy

Liquid biopsies offer a noninvasive way to study cancer by analyzing circulating tumor DNA in body fluids. However, in pediatric brain tumors, the small amount of ctDNA in cerebrospinal fluid has limited... Read more

Immunology

view channel
Image: The TmS computational biomarker analyzes tumor gene expression and microenvironment data to guide treatment decisions (Photo courtesy of MD Anderson Cancer Center)

New Biomarker Predicts Chemotherapy Response in Triple-Negative Breast Cancer

Triple-negative breast cancer is an aggressive form of breast cancer in which patients often show widely varying responses to chemotherapy. Predicting who will benefit from treatment remains challenging,... Read more

Pathology

view channel
Image: Powered by OptraSCAN’s patented OS‑SiA technology, the platform performs scanning, indexing, and AI‑driven analysis simultaneously (Photo courtesy of OptraSCAN)

New AI-Driven Platform Standardizes Tuberculosis Smear Microscopy Workflow

Sputum smear microscopy remains central to tuberculosis treatment monitoring and follow-up, particularly in high‑burden settings where serial testing is routine. Yet consistent, repeatable bacillary assessment... Read more

Industry

view channel
Image: QuidelOrtho has entered into a strategic supply agreement with Lifotronic to expand its global immunoassay portfolio (Photo courtesy of QuidelOrtho)

QuidelOrtho Collaborates with Lifotronic to Expand Global Immunoassay Portfolio

QuidelOrtho (San Diego, CA, USA) has entered a long-term strategic supply agreement with Lifotronic Technology (Shenzhen, China) to expand its global immunoassay portfolio and accelerate customer access... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.